Barimbao, Marygrace .
HRN: 04-16-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/29/2023
10/05/2023
IV
500mg
Q8
Sp CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes